Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin

Nicola Torrance, Blair Hamilton Smith, Margaret Camilla Watson, Michael I. Bennett

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Background. Neuropathic pain is widely recognized as one of the most difficult pain syndromes to treat and presents a significant challenge for pain clinicians and GPs.

Methods. The Self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire, recently validated for identifying pain of predominantly neuropathic origin (POPNO), was sent to 6000 adults identified from general practices in the UK. The questionnaire also contained items about chronic pain identification, medications and treatments received for pain and the pain relief these provided.

Results. In total, 1420/3002 (48%) of respondents indicated that they suffered with any chronic pain. These were further categorized as those with chronic pain who were S-LANSS negative ['chronic pain (non-POPNO)' group, n = 1179] and those with chronic pain who were S-LANSS positive, indicating the presence of POPNO ('chronic POPNO' group, n = 241). Questions relating to treatments and medications were completed by 88% of the respondents (1244/1420). The chronic POPNO group was more likely to receive multiple pain medications (37% versus 21% took two or more pain medications, P < 0.001) and stronger painkillers [e.g. opioids odds ratio 1.94; 95% confidence interval 1.10, 3.42]. Despite this, they reported less effective pain relief than the non-POPNO chronic pain group.

Conclusion. Patients in primary care reporting chronic pain were found generally to obtain incomplete relief from their medication with chronic POPNO patients reporting less relief. It is important that patients with any chronic pain are identified and managed appropriately according to their distinct treatment needs.

Original languageEnglish
Pages (from-to)481-485
Number of pages5
JournalFamily Practice
Volume24
Issue number5
Early online date1 Aug 2007
DOIs
Publication statusPublished - Oct 2007

Keywords

  • chronic pain
  • neuropathic pain
  • primary care
  • S-LANSS
  • treatment
  • epidemiology
  • mechanisms
  • Chronic pain

Cite this

Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. / Torrance, Nicola; Smith, Blair Hamilton; Watson, Margaret Camilla; Bennett, Michael I.

In: Family Practice, Vol. 24, No. 5, 10.2007, p. 481-485.

Research output: Contribution to journalArticle

Torrance, Nicola ; Smith, Blair Hamilton ; Watson, Margaret Camilla ; Bennett, Michael I. / Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. In: Family Practice. 2007 ; Vol. 24, No. 5. pp. 481-485.
@article{0a44dc33fd0b42378bdc4f49125a74dd,
title = "Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin",
abstract = "Background. Neuropathic pain is widely recognized as one of the most difficult pain syndromes to treat and presents a significant challenge for pain clinicians and GPs.Methods. The Self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire, recently validated for identifying pain of predominantly neuropathic origin (POPNO), was sent to 6000 adults identified from general practices in the UK. The questionnaire also contained items about chronic pain identification, medications and treatments received for pain and the pain relief these provided.Results. In total, 1420/3002 (48{\%}) of respondents indicated that they suffered with any chronic pain. These were further categorized as those with chronic pain who were S-LANSS negative ['chronic pain (non-POPNO)' group, n = 1179] and those with chronic pain who were S-LANSS positive, indicating the presence of POPNO ('chronic POPNO' group, n = 241). Questions relating to treatments and medications were completed by 88{\%} of the respondents (1244/1420). The chronic POPNO group was more likely to receive multiple pain medications (37{\%} versus 21{\%} took two or more pain medications, P < 0.001) and stronger painkillers [e.g. opioids odds ratio 1.94; 95{\%} confidence interval 1.10, 3.42]. Despite this, they reported less effective pain relief than the non-POPNO chronic pain group.Conclusion. Patients in primary care reporting chronic pain were found generally to obtain incomplete relief from their medication with chronic POPNO patients reporting less relief. It is important that patients with any chronic pain are identified and managed appropriately according to their distinct treatment needs.",
keywords = "chronic pain, neuropathic pain, primary care, S-LANSS, treatment, epidemiology, mechanisms, Chronic pain",
author = "Nicola Torrance and Smith, {Blair Hamilton} and Watson, {Margaret Camilla} and Bennett, {Michael I.}",
year = "2007",
month = "10",
doi = "10.1093/fampra/cmm042",
language = "English",
volume = "24",
pages = "481--485",
journal = "Family Practice",
issn = "0263-2136",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin

AU - Torrance, Nicola

AU - Smith, Blair Hamilton

AU - Watson, Margaret Camilla

AU - Bennett, Michael I.

PY - 2007/10

Y1 - 2007/10

N2 - Background. Neuropathic pain is widely recognized as one of the most difficult pain syndromes to treat and presents a significant challenge for pain clinicians and GPs.Methods. The Self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire, recently validated for identifying pain of predominantly neuropathic origin (POPNO), was sent to 6000 adults identified from general practices in the UK. The questionnaire also contained items about chronic pain identification, medications and treatments received for pain and the pain relief these provided.Results. In total, 1420/3002 (48%) of respondents indicated that they suffered with any chronic pain. These were further categorized as those with chronic pain who were S-LANSS negative ['chronic pain (non-POPNO)' group, n = 1179] and those with chronic pain who were S-LANSS positive, indicating the presence of POPNO ('chronic POPNO' group, n = 241). Questions relating to treatments and medications were completed by 88% of the respondents (1244/1420). The chronic POPNO group was more likely to receive multiple pain medications (37% versus 21% took two or more pain medications, P < 0.001) and stronger painkillers [e.g. opioids odds ratio 1.94; 95% confidence interval 1.10, 3.42]. Despite this, they reported less effective pain relief than the non-POPNO chronic pain group.Conclusion. Patients in primary care reporting chronic pain were found generally to obtain incomplete relief from their medication with chronic POPNO patients reporting less relief. It is important that patients with any chronic pain are identified and managed appropriately according to their distinct treatment needs.

AB - Background. Neuropathic pain is widely recognized as one of the most difficult pain syndromes to treat and presents a significant challenge for pain clinicians and GPs.Methods. The Self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire, recently validated for identifying pain of predominantly neuropathic origin (POPNO), was sent to 6000 adults identified from general practices in the UK. The questionnaire also contained items about chronic pain identification, medications and treatments received for pain and the pain relief these provided.Results. In total, 1420/3002 (48%) of respondents indicated that they suffered with any chronic pain. These were further categorized as those with chronic pain who were S-LANSS negative ['chronic pain (non-POPNO)' group, n = 1179] and those with chronic pain who were S-LANSS positive, indicating the presence of POPNO ('chronic POPNO' group, n = 241). Questions relating to treatments and medications were completed by 88% of the respondents (1244/1420). The chronic POPNO group was more likely to receive multiple pain medications (37% versus 21% took two or more pain medications, P < 0.001) and stronger painkillers [e.g. opioids odds ratio 1.94; 95% confidence interval 1.10, 3.42]. Despite this, they reported less effective pain relief than the non-POPNO chronic pain group.Conclusion. Patients in primary care reporting chronic pain were found generally to obtain incomplete relief from their medication with chronic POPNO patients reporting less relief. It is important that patients with any chronic pain are identified and managed appropriately according to their distinct treatment needs.

KW - chronic pain

KW - neuropathic pain

KW - primary care

KW - S-LANSS

KW - treatment

KW - epidemiology

KW - mechanisms

KW - Chronic pain

U2 - 10.1093/fampra/cmm042

DO - 10.1093/fampra/cmm042

M3 - Article

VL - 24

SP - 481

EP - 485

JO - Family Practice

JF - Family Practice

SN - 0263-2136

IS - 5

ER -